Effect of four probiotic strains and Escherichia coli O157:H7 on tight junction integrity and cyclo-oxygenase expression

Research in Microbiology

Volumn 159, Issue 9-10, 2008, Pages 692-698

  Putaala, Heli ^a   Salusjärvi, Tuomas ^a   Nordström, Malin ^a   Saarinen, Markku ^a   Ouwehand, Arthur C ^a   Bech Hansen, Egon ^b   Rautonen, Nina ^a  

^a Danisco Finland Oy   (Finland)

^b Danisco Cultures Division   (France)

Author keywords

Bifidobacteria; Caco 2; Cyclo oxygenase; EHEC O157:H7; Lactobacilli; Probiotics; Tight junction

Indexed keywords

PROBIOTIC AGENT; PROSTAGLANDIN SYNTHASE;

ARTICLE; BACTERIAL CELL; BACTERIAL STRAIN; BIFIDOBACTERIUM ANIMALIS; CELL FREE SYSTEM; CONTROLLED STUDY; ESCHERICHIA COLI; HUMAN; HUMAN CELL; LACTOBACILLUS ACIDOPHILUS; NONHUMAN; PRIORITY JOURNAL; SUPERNATANT; TIGHT JUNCTION;

BIFIDOBACTERIUM; CACO-2 CELLS; COLON; ESCHERICHIA COLI O157; HUMANS; LACTOBACILLUS; PROBIOTICS; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; TIGHT JUNCTIONS;

BACTERIA (MICROORGANISMS); BIFIDOBACTERIUM ANIMALIS SUBSP. LACTIS; ESCHERICHIA COLI; LACTOBACILLUS ACIDOPHILUS NCFM; LACTOBACILLUS SALIVARIUS;

EID: 56949094299     PISSN: 09232508     EISSN: 17697123     Source Type: Journal    
DOI: 10.1016/j.resmic.2008.08.002     Document Type: Article

References (39)

1. Apajalahti J.H., Kettunen H., Kettunen A., Holben W.E., Nurminen P.H., Rautonen N., and Mutanen M. Culture-independent microbial community analysis reveals that inulin in the diet primarily affects previously unknown bacteria in the mouse cecum. Appl. Environ. Microbiol. 68 (2002) 4986-4995
2. Asahara T., Shimizu K., Nomoto K., Hamabata T., Ozawa A., and Takeda Y. Probiotic bifidobacteria protect mice from lethal infection with Shiga toxin-producing Escherichia coli O157:H7. Infect. Immun. 72 (2004) 2240-2247
3. Belley A., Keller K., Gottke M., and Chadee K. Intestinal mucins in colonization and host defense against pathogens. Am. J. Trop. Med. Hyg. 60 (1999) 10-15
4. Bongaerts G.P., and Severijnen R.S. Preventive and curative effects of probiotics in atopic patients. Med. Hypotheses. 64 (2005) 1089-1092
5. Broekaert I.J., Nanthakumar N.N., and Walker W.A. Secreted probiotic factors ameliorate enteropathogenic infection in zinc-deficient human Caco-2 and T84 cell lines. Pediatr. Res. 62 (2007) 139-144
6. Dahan S., Busuttil V., Imbert V., Peyron J.F., Rampal P., and Czerucka D. Enterohemorrhagic Escherichia coli infection induces interleukin-8 production via activation of mitogen-activated protein kinases and the transcription factors NF-kappaB and AP-1 in T84 cells. Infect. Immun. 70 (2002) 2304-2310
7. Dean J.L., Brook M., Clark A.R., and Saklatvala J. p38 mitogen-activated protein kinase regulates cyclooxygenase-2 mRNA stability and transcription in lipopolysaccharide-treated human monocytes. J. Biol. Chem. 274 (1999) 264-269
8. Duncan S.H., Louis P., and Flint H.J. Lactate-utilizing bacteria, isolated from human feces, that produce butyrate as a major fermentation product. Appl. Environ. Microbiol. 70 (2004) 5810-5817
9. Eckmann L., Stenson W.F., Savidge T.C., Lowe D.C., Barrett K.E., Fierer J., Smith J.R., and Kagnoff M.F. Role of intestinal epithelial cells in the host secretory response to infection by invasive bacteria. Bacterial entry induces epithelial prostaglandin h synthase-2 expression and prostaglandin E2 and F2alpha production. J. Clin. Invest. 100 (1997) 296-309
10. Fasano A., and Nataro J.P. Intestinal epithelial tight junctions as targets for enteric bacteria-derived toxins. Adv. Drug Deliv. Rev. 56 (2004) 795-807
11. Gagnon M., Kheadr E.E., Dabour N., Richard D., and Fliss I. Effect of Bifidobacterium thermacidophilum probiotic feeding on enterohemorrhagic Escherichia coli O157:H7 infection in BALB/c mice. Int. J. Food Microbiol. 111 (2006) 26-33
12. Gill H.S., Rutherfurd K.J., Cross M.L., and Gopal P.K. Enhancement of immunity in the elderly by dietary supplementation with the probiotic Bifidobacterium lactis HN019. Am. J. Clin. Nutr. 74 (2001) 833-839
13. Gonzalez P.K., Doctrow S.R., Malfroy B., and Fink M.P. Role of oxidant stress and iron delocalization in acidosis-induced intestinal epithelial hyperpermeability. Shock 8 (1997) 108-114
14. Gopal P.K., Prasad J., Smart J., and Gill H.S. In vitro adherence properties of Lactobacillus rhamnosus DR20 and Bifidobacterium lactis DR10 strains and their antagonistic activity against an enterotoxigenic Escherichia coli. Int. J. Food Microbiol. 67 (2001) 207-216
15. Huang J.S., Bousvaros A., Lee J.W., Diaz A., and Davidson E.J. Efficacy of probiotic use in acute diarrhea in children: a meta-analysis. Dig. Dis. Sci. 47 (2002) 2625-2634
16. Isolauri E., Sutas Y., Kankaanpaa P., Arvilommi H., and Salminen S. Probiotics: effects on immunity. Am. J. Clin. Nutr. 73 (2001) 444S-450S
17. Kaper J.B., Nataro J.P., and Mobley H.L. Pathogenic Escherichia coli. Nat. Rev. Microbiol. 2 (2004) 123-140
18. Karczewski J., and Groot J. Molecular physiology and pathophysiology of tight junctions III. Tight junction regulation by intracellular messengers: differences in response within and between epithelia. Am. J. Physiol. Gastrointest. Liver Physiol. 279 (2000) G660-G665
19. Kinoshita H., Uchida H., Kawai Y., Kitazawa H., Miura K., Shiiba K., Horii A., and Saito T. Quantitative evaluation of adhesion of lactobacilli isolated from human intestinal tissues to human colonic mucin using surface plasmon resonance (BIACORE assay). J. Appl. Microbiol. 102 (2007) 116-123
20. Klingberg T.D., Pedersen M.H., Cencic A., and Budde B.B. Application of measurements of transepithelial electrical resistance of intestinal epithelial cell monolayers to evaluate probiotic activity. Appl. Environ. Microbiol. 71 (2005) 7528-7530
21. Mahkonen A., Putaala H., Mustonen H., Rautonen N., and Puolakkainen P. Lactobacillus acidophilus 74-2 and butyrate induce cyclooxygenase (Cox)-1 expression in gastric cancer cells. Immunopharmacol. Immunotoxicol. 30 (2008) 503-518
22. Matsumoto H., Erickson R.H., Gum J.R., Yoshioka M., Gum E., and Kim Y.S. Biosynthesis of alkaline phosphatase during differentiation of the human colon cancer cell line Caco-2. Gastroenterology 98 (1990) 1199-1207
23. Mattar A.F., Teitelbaum D.H., Drongowski R.A., Yongyi F., Harmon C.M., and Coran A.G. Probiotics up-regulate MUC-2 mucin gene expression in a Caco-2 cell-culture model. Pediatr. Surg. Int. 18 (2002) 586-590
24. N'Guessan P.D., Hippenstiel S., Etouem M.O., Zahlten J., Beermann W., Lindner D., Opitz B., Witzenrath M., Rosseau S., Suttorp N., and Schmeck B. Streptococcus pneumoniae induced p38 MAPK- and NF-{kappa}B-dependent COX-2 expression in human lung epithelium. Am. J. Physiol. Lung Cell. Mol. Physiol. 290 (2006) L1131-L1138
25. Nurmi J.T., Puolakkainen P.A., and Rautonen N.E. Bifidobacterium lactis sp. 420 up-regulates cyclooxygenase (Cox)-1 and down-regulates Cox-2 gene expression in a Caco-2 cell culture model. Nutr. Cancer. 51 (2005) 83-92
26. Nusrat A., Turner J.R., and Madara J.L. Molecular physiology and pathophysiology of tight junctions. IV. Regulation of tight junctions by extracellular stimuli: nutrients, cytokines, and immune cells. Am. J. Physiol. Gastrointest. Liver Physiol. 279 (2000) G851-G857
27. Otte J.M., and Podolsky D.K. Functional modulation of enterocytes by gram-positive and gram-negative microorganisms. Am. J. Physiol. Gastrointest. Liver Physiol. 286 (2004) G613-G626
28. Philpott D.J., McKay D.M., Mak W., Perdue M.H., and Sherman P.M. Signal transduction pathways involved in enterohemorrhagic Escherichia coli-induced alterations in T84 epithelial permeability. Infect. Immun. 66 (1998) 1680-1687
29. Qin N., Zhang S.P., Reitz T.L., Mei J.M., and Flores C.M. Cloning, expression, and functional characterization of human cyclooxygenase-1 splicing variants: evidence for intron 1 retention. J. Pharmacol. Exp. Ther. 315 (2005) 1298-1305
30. Salminen S., Bouley C., Boutron-Ruault M.C., Cummings J.H., Franck A., Gibson G.R., Isolauri E., Moreau M.C., Roberfroid M., and Rowland I. Functional food science and gastrointestinal physiology and function. Br. J. Nutr. 80 (1998) S147-S171
31. Sambuy Y., De Angelis I., Ranaldi G., Scarino M.L., Stammati A., and Zucco F. The Caco-2 cell line as a model of the intestinal barrier: influence of cell and culture-related factors on Caco-2 cell functional characteristics. Cell Biol. Toxicol. 21 (2005) 1-26
32. Sazawal S., Hiremath G., Dhingra U., Malik P., Deb S., and Black R.E. Efficacy of probiotics in prevention of acute diarrhea: a meta-analysis of masked, randomised, placebo-controlled trials. Lancet Infect. Dis. 6 (2006) 374-382
33. Sherman P.M., Johnson-Henry K.C., Yeung H.P., Ngo P.S., Goulet J., and Tompkins T.A. Probiotics reduce enterohemorrhagic Escherichia coli O157:H7- and enteropathogenic E. coli O127:H6-induced changes in polarized T84 epithelial cell monolayers by reducing bacterial adhesion and cytoskeletal rearrangements. Infect. Immun. 73 (2005) 5183-5188
34. Shu Q., and Gill H.S. A dietary probiotic (Bifidobacterium lactis HN019) reduces the severity of Escherichia coli O157:H7 infection in mice. Med. Microbiol. Immunol. (Berl.) 189 (2001) 147-152
35. Simmons D.L., Botting R.M., and Hla T. Cyclooxygenase isozymes: the biology of prostaglandin synthesis and inhibition. Pharmacol. Rev. 56 (2004) 387-437
36. Soler A.P., Miller R.D., Laughlin K.V., Carp N.Z., Klurfeld D.M., and Mullin J.M. Increased tight junctional permeability is associated with the development of colon cancer. Carcinogenesis 20 (1999) 1425-1431
37. Tiihonen K., Tynkkynen S., Ouwehand A., Ahlroos T., and Rautonen N. The effect of ageing with and without non-steroidal anti-inflammatory drugs on gastrointestinal microbiology and immunology. Br. J. Nutr. 100 (2008) 130-137
38. Yamashita S., Konishi K., Yamazaki Y., Taki Y., Sakane T., Sezaki H., and Furuyama Y. New and better protocols for a short-term Caco-2 cell culture system. J. Pharm. Sci. 91 (2002) 669-679
39. Zhou J.S., and Gill H.S. Immunostimulatory probiotic Lactobacillus rhamnosus HN001 and Bifidobacterium lactis HN019 do not induce pathological inflammation in mouse model of experimental autoimmune thyroiditis. Int. J. Food Microbiol. 103 (2005) 97-104